Natural Capsules Limited has announced that its board of directors will meet on Wednesday, May 27, 2026. The primary agenda for the meeting is to consider and approve the audited standalone and consolidated financial statements of the company for the quarter and year ended March 31, 2026.

The meeting is being convened in accordance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) 2015. Apart from the financial results, the board will also discuss any other matters with the permission of the Chairman.

Trading Window Closure

In compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company’s internal code of conduct, the trading window for dealing in the equity shares of the company has been closed. This restriction applies to all designated persons and their immediate relatives.

The closure of the trading window became effective from April 1, 2026. It will remain closed until the conclusion of 48 hours after the declaration of the financial results for the quarter and year ended March 31, 2026.

Meeting Details

The following table summarizes the key details regarding the upcoming board meeting and the trading window closure:

Natural Capsules Limited has announced the resignation of Ms. Pranjal Deshmukh from her position as Company Secretary and Compliance Officer, effective from the close of business hours on April 25, 2026. The company informed both BSE Limited and National Stock Exchange of India Limited about this key managerial personnel change in compliance with regulatory requirements.

Resignation Details

Ms. Pranjal Deshmukh submitted her resignation letter on March 27, 2026, requesting relief from her duties as Company Secretary and Compliance Officer. The resignation becomes effective from the close of business hours on April 25, 2026.

Regulatory Compliance

The announcement was made in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Natural Capsules Limited provided comprehensive details as required under the regulatory framework, including the resignation letter and confirmation of no additional material reasons for the departure.

Key Highlights

The resignation encompasses several important aspects:

• Ms. Deshmukh confirmed no other material reasons exist beyond pursuing better career opportunities
• The company received formal confirmation regarding the singular reason for resignation
• All necessary regulatory disclosures have been completed as per SEBI requirements
• The resignation letter was formally accepted by the company management

Company Response

Natural Capsules Limited, through Managing Director Sunil L Mundra (DIN: 00214304), formally communicated the resignation to stock exchanges. The company acknowledged Ms. Deshmukh's contributions during her tenure and confirmed arrangements for necessary regulatory filings with the Registrar of Companies.

The resignation represents a routine corporate governance matter, with the company ensuring full compliance with all applicable regulations and disclosure requirements for key managerial personnel changes.